Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Take a Chance? Stroke Risk Management After Atrial Fibrillation Ablation.

Heart rhythm·2026
Same author

Robot-Assisted Coronary Artery Bypass Versus Percutaneous Coronary Intervention in Patients With Coronary Artery Disease: A Meta-Analysis.

Innovations (Philadelphia, Pa.)·2026
Same author

The Effect of Restrictive vs Liberal Blood Transfusion Strategy on Subsequent Myocardial Infarction Type.

JACC. Advances·2026
Same author

Etiological myocardial injury classification versus binary myocardial infarction classification in the multi-ethnic study of atherosclerosis (MESA).

American journal of preventive cardiology·2026
Same author

Blood Levels of Angiotensinogen and Risk of Ischemic Stroke: The Multi-Ethnic Study of Atherosclerosis.

Journal of the American Heart Association·2026
Same author

Transcatheter Versus Surgical Aortic Valve Replacement in Patients Aged 50 to 65 Years: A Propensity Score-Matched Five-Year Study.

Cardiology·2026
Same journal

Public Health Response to Clade Ib Mpox with Multiple Exposures in Congregate Living Settings - New Hampshire, February 2025.

NEJM evidence·2026
Same journal

Berberine-Ursodeoxycholate - Bringing Traditional Chinese Medicine to Our World.

NEJM evidence·2026
Same journal

Outbreak of Legionnaires' Disease Associated with Cooling Tower Systems in Central Harlem.

NEJM evidence·2026
Same journal

Immunotherapy for Fertility in Autoimmune Premature Ovarian Insufficiency.

NEJM evidence·2026
Same journal

A Randomized Trial of Interval Likelihood Ratios for Clinical Decision-Making.

NEJM evidence·2026
Same journal

Evidence for Evidence-Based Medicine - A Call for Some Theory and a New Problem.

NEJM evidence·2026
See all related articles

Related Experiment Video

Updated: Jul 7, 2026

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
13:42

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion

Published on: July 17, 2012

28.8K

Restrictive versus Liberal Transfusion in Myocardial Infarction - A Patient-Level Meta-Analysis.

Jeffrey L Carson1, Dean A Fergusson2, Helaine Noveck1

  • 1Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.

NEJM Evidence
|December 23, 2024
PubMed
Summary
This summary is machine-generated.

A restrictive red blood cell transfusion strategy for acute myocardial infarction (MI) and anemia did not differ in 30-day mortality or MI. However, restrictive transfusion was linked to higher 6-month all-cause mortality.

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.4K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.3K

Related Experiment Videos

Last Updated: Jul 7, 2026

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
13:42

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion

Published on: July 17, 2012

28.8K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.4K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.3K

Area of Science:

  • Cardiology
  • Hematology
  • Clinical Trials

Background:

  • Clinical guidelines lack recommendations for red blood cell transfusion thresholds in acute myocardial infarction (MI) with anemia.
  • The Myocardial Infarction and Transfusion (MINT) trial prompted a meta-analysis of individual patient data.
  • This study evaluates restrictive versus liberal blood transfusion strategies in MI patients with anemia.

Purpose of the Study:

  • To compare the efficacy of restrictive versus liberal red blood cell transfusion strategies.
  • To assess the impact of transfusion thresholds on mortality and MI in patients with acute MI and anemia.
  • To provide evidence-based recommendations for transfusion management in this patient population.

Main Methods:

  • Individual patient data meta-analysis of four randomized controlled trials.
  • Inclusion criteria: patients with MI and anemia.
  • Intervention: restrictive (7-8 g/dl) versus liberal (10 g/dl) red cell transfusion strategies.
  • Primary outcome: composite of 30-day mortality or MI.

Main Results:

  • 4311 patients included; primary outcome occurred in 15.4% (restrictive) vs. 13.8% (liberal).
  • No significant difference in 30-day MI or mortality (RR 1.13, 95% CI 0.97-1.30).
  • Higher 30-day cardiac death in restrictive group (5.5% vs. 3.7%); similar heart failure rates.
  • Increased 6-month all-cause mortality observed with restrictive strategy (HR 1.08, 95% CI 1.05-1.11).

Conclusions:

  • Individual patient data meta-analysis did not confirm a difference in the primary composite outcome of 30-day MI or mortality.
  • A restrictive transfusion strategy was associated with increased all-cause mortality at 6 months.
  • Findings suggest caution with restrictive transfusion thresholds in MI patients with anemia.